Results 31 to 40 of about 8,773 (178)

Fatal case of cephalexin-induced toxic epidermal necrolysis

open access: yesSAGE Open Medical Case Reports, 2014
Purpose: To describe a case of toxic epidermal necrolysis likely caused by cephalexin with a review of the literature. Case: An 80-year-old male with a known allergy to cephalosporins, residing at a long-term acute care hospital, received cephalexin for ...
Matthew J Hafermann   +3 more
doaj   +1 more source

Intravenous -acetylcysteine in severe cutaneous drug reaction treatment: A case series

open access: yesSAGE Open Medical Case Reports, 2020
Drug-induced serious adverse reaction is an unpleasant event with high rate of mortality. Stevens–Johnson Syndrome and toxic epidermal necrolysis are most common among the serious adverse drug reactions.
Md Jahidul Hasan, Raihan Rabbani
doaj   +1 more source

Clinical features of Stevens — Johnson syndrome and toxic epidermal necrolysis: An observational cohort retrospective study

open access: yesКубанский научный медицинский вестник
Background. Stevens — Johnson syndrome and toxic epidermal necrolysis are severe diseases featuring lesions of the mucous membranes and skin, with a possible lethal outcome. These diseases are most often triggered by various infections and medications, e.
G. M. Nurtdinova   +6 more
doaj   +1 more source

Acute compartment syndrome of the forearm as a rare complication of toxic epidermal necrolysis: a case report

open access: yesJournal of Medical Case Reports, 2012
Introduction Toxic epidermal necrolysis lies within the spectrum of severe cutaneous adverse reactions induced by drugs, affecting skin and mucous membranes.
Kamal Tamer   +3 more
doaj   +1 more source

Increased predisposition of sjs ten in COVID-19 patients, presenting as post COVID complication: Report of two cases

open access: yesIndian Dermatology Online Journal, 2022
We report two consecutive cases of toxic epidermal necrolysis presented to our emergency department in the past 5 months. Both patients had history of fever prior to the onset of skin manifestations and showed radiological findings suggestive of COVID-19
Shayna Aulakh   +3 more
doaj   +1 more source

Toxic Epidermal Necrolysis

open access: yesJournal of Rawalpindi Medical College, 2020
Toxic epidermal necrolysis (TEN) is the most severe form of drug-induced skin reaction and includes denudation of >30% of total body surface area. The mechanism of disease is not completely understood, but immunologic mechanisms, cytotoxic reactions, and
Syed Naveed Ali Shah   +2 more
doaj  

Carbamazepine-Induced Toxic Epidermal Necrolysis

open access: yesJournal of Integrated Health Sciences, 2018
Toxic epidermal necrolysis (TEN) is an uncommon; however, life-threatening dermatological condition which occurs most frequently by the use of drugs. Some group of medications, such as antiepileptics, antibiotics as well as antivirals, can induce such ...
Kushal Gohel   +3 more
doaj   +1 more source

A case series of allopurinol-induced toxic epidermal necrolysis

open access: yesIndian Journal of Dermatology, 2011
This is a case series of allopurinol-induced toxic epidermal necrolysis. Revisiting the indications of using allopurinol in asymptomatic hyperuricemia and a critical reappraisal of the safety profile of allopurinol is done in this article.
Harneet Ranu   +2 more
doaj   +1 more source

Risk Factors for Cutaneous Immune‐Related Adverse Events in the Japanese Population: A Retrospective Single‐Center Cohort Study

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Immune checkpoint inhibitor (ICI)‐driven alterations in the immune system can induce immune‐related adverse events (irAEs). Cutaneous irAEs are notable for being the most common and for their early onset; however, the risk factors underlying their development and severity remain unclear. In this study, we retrospectively analyzed 1224 Japanese
Tomoya Watanabe   +4 more
wiley   +1 more source

Toxic Epidermal Necrolysis

open access: yesEurasian Journal of Medicine, 2019
-
Gülten Gürel   +2 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy